Thomas King of Brooklyn, NY appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. Thomas King appears on 8 filing roles across Form D (7), Form ADV (1).
| Filed | Source | Entity | Role | Location |
|---|---|---|---|---|
| 2026-01-30 | Form ADV | SARVER VROOMAN WEALTH ADVISORS LLC | PARTNER | KANSAS CITY, MO |
| 2009-03-24 | Form D | THERMASOURCE LLC | Director | SANTA ROSA, CA |
| 2016-10-26 | Form D | EVOWORX INC | Director | SEATTLE, WA |
| 2019-09-12 | Form D | Faraday Pharmaceuticals, Inc. | Director | SEATTLE, WA |
| 2018-11-13 | Form D | Concentric Analgesics, Inc. | Director | SAN FRANCISCO, CA |
| 2018-02-12 | Form D | Satsuma Pharmaceuticals, Inc. | Director | South San Francisco, CA |
| 2025-10-09 | Form D | Limivorous Preferred Fund LP | Executive Officer | BROOKLYN, NY |
| 2024-09-13 | Form D | Black Ice Data Inc. | Director | MERIDIAN, ID |